{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:00:51Z","timestamp":1759010451105,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institutional Review Board"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.04.025","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T06:07:01Z","timestamp":1398319621000},"page":"3548-3554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Tracy","family":"Pondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles E.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey W.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry L.","family":"Keyserling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janiine","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2002","author":"Bioport Corporation","series-title":"Anthrax Vaccine Adsorbed (BIOTHRAX\u2122) Package Insert","key":"10.1016\/j.vaccine.2014.04.025_bib0005"},{"year":"1998","author":"Cohen","series-title":"Implementation of the Anthrax Vaccination Program for the Total Force","key":"10.1016\/j.vaccine.2014.04.025_bib0010"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.025_bib0015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/pds.936","article-title":"Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"13","author":"Sever","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"15","key":"10.1016\/j.vaccine.2014.04.025_bib0020","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(02)00723-5","article-title":"Comprehensive systematic surveillance for adverse events of anthrax vaccine adsorbed, US Armed Forces 1998\u20132000","volume":"21","author":"Lange","year":"2003","journal-title":"Vaccine"},{"year":"2002","author":"Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-up Agency","series-title":"The anthrax vaccine. Is it safe? Does it work?","key":"10.1016\/j.vaccine.2014.04.025_bib0025"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2014.04.025_bib0030","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2014.04.025_bib0035","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2014.04.025_bib0040","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1016\/S0264-410X(03)00435-3","article-title":"Using a structured medical note for determining the safety profile of anthrax vaccine for US soldiers in Korea","volume":"21","author":"Hoffman","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.025_bib0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/aje\/kwn159","article-title":"Birth defects among infants born to women who received anthrax vaccine in pregnancy","volume":"168","author":"Ryan","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.025_bib0050","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.287.12.1556","article-title":"Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women","volume":"287","author":"Weisen","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.025_bib0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.fertnstert.2004.07.965","article-title":"Anthrax vaccine does not affect semen parameters, embryo quality, or pregnancy outcome in couples with a vaccinated male military service member","volume":"83","author":"Catherino","year":"2005","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.025_bib0060","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.jom.0000141664.90587.47","article-title":"Disability among US Army personnel vaccinated against anthrax","volume":"46","author":"Sulsky","year":"2004","journal-title":"J Occup Environ Med"},{"issue":"35","key":"10.1016\/j.vaccine.2014.04.025_bib0065","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1016\/j.vaccine.2011.06.028","article-title":"Risk of disability for US army personnel vaccinated against anthrax, 1998\u20132005","volume":"29","author":"Sulsky","year":"2011","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2014.04.025_bib0070","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1016\/j.vaccine.2012.07.067","article-title":"Disability among US Army veterans vaccinated against anthrax","volume":"30","author":"Sulsky","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.025_bib0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/JOM.0b013e318157d305","article-title":"Assessing the safety of anthrax immunization in US Army aircrew members via physical examination","volume":"49","author":"Downing","year":"2007","journal-title":"J Occup Environ Med"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.025_bib0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019\u2014autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"issue":"9068","key":"10.1016\/j.vaccine.2014.04.025_bib0085","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(97)01164-1","article-title":"Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?","volume":"349","author":"Rook","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.025_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1300\/J092v11n02_03","article-title":"High prevalence of mycoplasmal infection in symptomatic (chronic fatigue syndrome) family members of mycoplasma-positive Gulf War Illness patients","volume":"11","author":"Nicolson","year":"2003","journal-title":"J Chronic Fatigue Syndr"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.025_bib0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08916930701197273","article-title":"Infection and vaccination in chronic fatigue syndrome: myth or reality?","volume":"40","author":"Appel","year":"2007","journal-title":"Autoimmunity"},{"year":"2002","author":"Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-up Agency","series-title":"An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program","key":"10.1016\/j.vaccine.2014.04.025_bib0100"},{"year":"2008","author":"Sun","series-title":"Biologics license application supplement approval letter","key":"10.1016\/j.vaccine.2014.04.025_bib0105"},{"unstructured":"CDC. Advisory Committee on Immunization Practices (ACIP) meeting minutes archive. n.d. <http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-feb09.pdf>.(accessed June 12, 2013).","key":"10.1016\/j.vaccine.2014.04.025_bib0110"},{"key":"10.1016\/j.vaccine.2014.04.025_bib0115","first-page":"1","article-title":"Use of Anthrax Vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"13","key":"10.1016\/j.vaccine.2014.04.025_bib0120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months","volume":"300","author":"Marano","year":"2008","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2014.04.025_bib0125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2013.10.039","article-title":"Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial","volume":"32","author":"Wright","year":"2014","journal-title":"Vaccine"},{"unstructured":"CDC. About BMI for Adults, Centers for Disease Control and Prevention. n.d. \u3008http:\/\/www.cdc.gov\/healthyweight\/assessing\/bmi\/adult_bmi\/index.html\u3009 (accessed January 25, 2013).","key":"10.1016\/j.vaccine.2014.04.025_bib0130"},{"issue":"10","key":"10.1016\/j.vaccine.2014.04.025_bib0135","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerg Infect Dis"},{"year":"1998","author":"ADVIA","series-title":"Centaur, ReadyPack and ACS 180","key":"10.1016\/j.vaccine.2014.04.025_bib0140"},{"issue":"9","key":"10.1016\/j.vaccine.2014.04.025_bib0145","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jclinepi.2006.12.001","article-title":"Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression","volume":"60","author":"Localio","year":"2007","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2014.04.025_bib0150","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pds.1657","article-title":"Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women","volume":"17","author":"Zhang","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.025_bib0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17d vaccines (Arilvax and YF-Vax) in a phase 3 multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.025_bib0160","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1542\/peds.96.3.584","article-title":"Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines","volume":"96","author":"Christy","year":"1995","journal-title":"Pediatrics"},{"issue":"29","key":"10.1016\/j.vaccine.2014.04.025_bib0165","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2014.04.025_bib0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4161\/hv.8476","article-title":"Sex differences in injection site reactions with human vaccines","volume":"5","author":"Cook","year":"2009","journal-title":"Hum Vaccin"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.025_bib0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2014.04.025_bib0180","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half-vs full-dose trivalent inactivated influenza vaccine (2004\u20132005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch Intern Med"},{"issue":"14","key":"10.1016\/j.vaccine.2014.04.025_bib0185","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.1996.00440130090009","article-title":"Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial","volume":"156","author":"Nichol","year":"1996","journal-title":"Arch Intern Med"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.04.025_bib0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.26719\/2003.9.1-2.152","article-title":"Effect of gender on reporting of MMR adverse events in Saudi Arabia","volume":"9","author":"Khalil","year":"2003","journal-title":"East Mediterr Health J"},{"issue":"6834","key":"10.1016\/j.vaccine.2014.04.025_bib0195","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/bmj.304.6834.1075","article-title":"Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine","volume":"304","author":"Benjamin","year":"1992","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.025_bib0200","doi-asserted-by":"crossref","first-page":"J282","DOI":"10.1016\/j.jaut.2011.11.013","article-title":"Sex affects immunity","volume":"38","author":"Pennell","year":"2012","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.vaccine.2014.04.025_bib0205","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1567-5769(01)00044-3","article-title":"Sex hormones as immunomodulators in health and disease","volume":"1","author":"Verthelyi","year":"2001","journal-title":"Int Immunopharmacol"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2014.04.025_bib0210","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1289\/ehp.99107s5681","article-title":"Gender and risk of autoimmune disease: possible role of estrogenic compounds","volume":"107","author":"Ahmed","year":"1999","journal-title":"Environ Health Perspect"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.025_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0950-3579(05)80240-7","article-title":"Sex hormones and the immune system\u2014Part 1. Human data","volume":"4","author":"Lahita","year":"1990","journal-title":"Bailli\u00e8re's Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.vaccine.2014.04.025_bib0220","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1515\/CCLM.2006.160","article-title":"Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT\u00ae analyzer","volume":"44","author":"Stricker","year":"2006","journal-title":"Clin Chem Lab Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:54:49Z","timestamp":1648878889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14005519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":44,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14005519"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}